FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension - PR Newswire (press release) PDF Print
PR Newswire (press release)
Monitor for worsening renal function in patients with renal impairment. In patients whose renal function may depend on the activity of the renin-angiotensin system, treatment with ACE inhibitors and ARBs has been associated with oliguria or progressive

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.